ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

SAJEM. 2019; 2(1): 40-42


Vasogenic Shock Secondary to an Intentional Overdose of Multiple Antihypertensives in a patient with Hypertrophic Cardiomyopathy

Muhammad Usman Ghani.



Abstract
Download PDF Cited by 0 ArticlesPost

We are reporting a case of intentional polypharmacy with beta blockers, calcium channel blockers, alpha adrenergic blockers and centrally acting antihypertensive agents in a young male with HCM. This unique presentation resulted in shock which didn't respond to all known interventions including intralipid. The patient finally responded to HIET and Vasopressin and after adrenaline was tapered and finally stopped. We feel early initiation of pure alpha agonist like vasopressin or phenylephrine could have been more successful in this scenario of hypotension and outflow obstruction.

In our literature search we came across a case report of combined B blocker/calcium channel blocker and amiodarone toxicity in a patient with HCM which responded well to intralipid. However, to our knowledge this is the first case report of life threatening overdose of B blocker, calcium channel blocker, alpha blocker and centrally acting antihypertensives in a patient with HCM.

Key words: Vasogenic shock, antihypertensives, toxicology, Hypertrophic cardiomyopathy, HIET







Bibliomed Article Statistics

30
30
30
26
24
20
36
33
53
45
35
33
R
E
A
D
S

17

12

12

7

14

13

11

9

10

31

25

18
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.